Masaru Hirano

Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the Hepatic Uptake of Pitavastatin in Humans

Masaru Hirano, Kazuya Maeda, Yoshihisa Shitara et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 442 citations

Pharmacy, Biochemistry, Pharmacology +16

Gemfibrozil and Its Glucuronide Inhibit the Organic Anion Transporting Polypeptide 2 (OATP2/OATP1B1:SLC21A6)-Mediated Hepatic Uptake and CYP2C8-Mediated Metabolism of Cerivastatin: Analysis of the Mechanism of the Clinically Relevant Drug-Drug Interaction between Cerivastatin and Gemfibrozil

Yoshihisa Shitara, Masaru Hirano, Hitoshi Sato et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 405 citations

Medicine, Pharmacokinetics, Pharmacology +17

DRUG-DRUG INTERACTION BETWEEN PITAVASTATIN AND VARIOUS DRUGS VIA OATP1B1

Masaru Hirano, Kazuya Maeda, Yoshihisa Shitara et al. · Drug Metabolism and Disposition · 2006 · 301 citations

Medicine, Biochemistry, Pharmacology +15

Involvement of BCRP (ABCG2) in the Biliary Excretion of Pitavastatin

Masaru Hirano, Kazuya Maeda, Soichiro Matsushima et al. · Molecular Pharmacology · 2005 · 256 citations

Medicine, Biochemistry, Pharmacology +17

Identification of the Hepatic Efflux Transporters of Organic Anions Using Double-Transfected Madin-Darby Canine Kidney II Cells Expressing Human Organic Anion-Transporting Polypeptide 1B1 (OATP1B1)/Multidrug Resistance-Associated Protein 2, OATP1B1/Multidrug Resistance 1, and OATP1B1/Breast Cancer Resistance Protein

Soichiro Matsushima, Kazuya Maeda, Chihiro Kondo et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 189 citations

Life Sciences, Biochemistry, Molecular Biology +17